GLT1D1: A Potential Drug Target and Biomarker for Diabetes and Inflammation

Target Name: GLT1D1

NCBI ID: G144423

GLT1D1

Other Name(s): glycosyltransferase 1 domain containing 1 | Glycosyltransferase 1 domain-containing protein 1 (isoform 1) | Glycosyltransferase 1 domain-containing protein 1 | GL1D1_HUMAN | Glycosyltransferase 1 domain containing 1, transcript variant 1 | GLT1D1 variant 1

GLT1D1: A Potential Drug Target and Biomarker for Diabetes and Inflammation

GLT1D1 (Glycosyltransferase 1 domain containing 1) is a gene that encodes a protein known as GLT1D1. GLT1D1 is a member of the GLT family of transmembrane proteins, which are involved in the transfer of glucose across cell membranes. The GLT1D1 protein is expressed in most tissues of the body and is involved in the uptake and internalization of glucose.

GLT1D1 is a 21-kDa protein that consists of a catalytic active center and a transmembrane region. The catalytic active center of GLT1D1 contains a catalytic domain that is responsible for the transfer of glucose across the cell membrane. The transmembrane region of GLT1D1 contains a unique glycosyltransferase 1 domain that is responsible for the attachment of the glucose unit to the protein.

The GLT1D1 gene has been identified as a potential drug target in the field of diabetes. GLT1D1 has been shown to play a role in the regulation of insulin sensitivity and glucose metabolism. Studies have shown that GLT1D1 is involved in the uptake and internalization of glucose, and that it is a key regulator of the glucose transporter GLUT1.

In addition to its role in glucose metabolism, GLT1D1 has also been shown to play a role in the regulation of inflammation. Studies have shown that GLT1D1 is involved in the regulation of inflammation and that it is a potential therapeutic target for the treatment of inflammatory diseases.

GLT1D1 is also a potential biomarker for the diagnosis and monitoring of diabetes. Studies have shown that GLT1D1 is expressed in the pancreatic beta cells and that it is involved in the regulation of insulin secretion. This suggests that GLT1D1 may be a useful biomarker for the diagnosis and monitoring of diabetes.

In conclusion, GLT1D1 is a gene that encodes a protein that is involved in the transfer of glucose across cell membranes. The GLT1D1 protein is a potential drug target and a potential biomarker for the diagnosis and monitoring of diabetes. Further research is needed to fully understand the role of GLT1D1 in glucose metabolism and inflammation.

Protein Name: Glycosyltransferase 1 Domain Containing 1

The "GLT1D1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GLT1D1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets